Scott Ugras, PhD

Scott Ugras is the Head of Corporate Development at Mirai Bio. His responsibilities span business development, corporate strategy, competitive intelligence, alliance management, and fundraising.

Prior to Mirai, Scott spent several years at Sarepta Therapeutics, most recently as the Clinical Development Lead for multiple neuromuscular gene therapy programs. He also spent several years in Corporate Strategy, where he drove multiple key initiatives across the company. Before Sarepta, Scott was a consultant with McKinsey & Company, where he led multiple projects with key biopharma companies, spanning diverse topics including strategy, R&D, business development and organizational improvement projects.

Scott has a PhD in Biochemistry and Molecular Biophysics from the University of Pennsylvania.